FDA Rejects Apricus Biosciences' Erectile Dysfunction Cream Vitaros Post author:Sam Post published:February 15, 2018 Post category:BioPharma The CRL indicates that the FDA cannot approve the NDA for Vitaros in its present form. Source: BioSpace You Might Also Like Array BioPharma Slaps $192M Lawsuit on AstraZeneca Over Cancer Drug Royalties February 1, 2018 J&J Wins FDA Nod for Erleada, the First Drug for Nonmetastatic Prostate Cancer February 14, 2018 Innoviva Files Preliminary Proxy Materials For 2017 Annual Meeting March 6, 2017
